Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2026 Earnings Call Transcript
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2026 Earnings Call Transcript May 6, 2026Castle Biosciences, Inc. reports earnings inline with expectations.
Castle Biosciences Inc (CSTL)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Portolan Capital Management George Mccabe | 1,350,283 | $33,149,448 | -22% | 1.76% |
| 2. | AIGH Investment Partners Orin Hirschman | 590,601 | $14,499,255 | -6% | 1.98% |
| 3. | Renaissance Technologies Jim Simons | 532,800 | $13,080,240 | +9% | 0.02% |
| 4. | Millennium Management Israel Englander | 353,319 | $8,673,981 | +15% | 0% |
| 5. | Tudor Investment Corp Paul Tudor Jones | 222,982 | $5,474,208 | +34% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.27 | 2,500 | $43,175.00 | 9,065 | 2023-06-05 | Filing | |
| $11.23 | 2,300 | $25,829.00 | 6,565 | 2023-06-05 | Filing | |
| $21.50 | 1,162 | $24,983.00 | 2,968 | 2022-11-29 | Filing | |
| $18.77 | 220 | $4,129.40 | 1,806 | 2022-05-12 | Filing | |
| $18.76 | 1,100 | $20,636.00 | 1,586 | 2022-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.59 | 41 | $925.99 | 2,224 | 2026-05-07 | Filing | |
| $22.59 | 41 | $925.99 | 2,224 | 2026-05-07 | Filing | |
| $22.59 | 41 | $925.99 | 2,224 | 2026-05-07 | Filing | |
| $22.59 | 41 | $925.99 | 2,224 | 2026-05-07 | Filing | |
| $22.59 | 168 | $3,794.28 | 39,214 | 2026-05-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,982,946 | $73,231,325 | 0% | |
| 2. | 2,758,335 | $67,717,124 | 0.67% | |
| 3. | 1,769,877 | $43,450,481 | 0.02% | |
| 4. | 1,177,522 | $28,908,165 | 0% | |
| 5. | 1,039,761 | $25,523,454 | 0.01% |
News See All
Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to Castle Biosciences Fourth Quarter and Full Year 2025 Conference Call. As a reminder, today's call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to Castle Biosciences' Third Quarter 2025 Conference Call. As a reminder, today's call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2025 Earnings Call Transcript
Operator: Good afternoon all, and thank you for joining us for the Castle Biosciences' Q2 2025 Earnings Call. As a reminder, this call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2025 Earnings Call Transcript
Operator: Good afternoon and welcome to Castle Biosciences First Quarter 2025 Conference Call. As a reminder, today's call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to Castle Biosciences Fourth Quarter and Full Year 2024 Conference Call. As a reminder, today's call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to Castle Biosciences Third Quarter 2024 Conference Call. As a reminder, today's call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to Castle Biosciences Second Quarter 2024 Conference Call. As a remainder, today's call is being recorded.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to Castle Biosciences First Quarter 2024 Conference Call. As a remainder, today's call is being recorded.
Hedge Fund Resource Center